This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Nov 22;362(9397):1686-7.

doi: 10.1016/S0140-6736(03)14880-5.

Can we pull the plug on warfarin in atrial fibrillation?

Freek W A Verheugt¹

Affiliations

PMID: 14643112
DOI: 10.1016/S0140-6736(03)14880-5

Comment

Can we pull the plug on warfarin in atrial fibrillation?

Freek W A Verheugt. Lancet. 2003.

. 2003 Nov 22;362(9397):1686-7.

doi: 10.1016/S0140-6736(03)14880-5.

Author

Freek W A Verheugt¹

Affiliation

¹ Heartcentre, University Medical Centre St Radboud, 6500 HB, Nijmegen, Netherlands. f.verheugt@cardio.umcn.nl

PMID: 14643112
DOI: 10.1016/S0140-6736(03)14880-5

No abstract available

PubMed Disclaimer

Comment in

Ximelagatran or warfarin in atrial fibrillation?
Eikelboom J, Hankey G. Eikelboom J, et al. Lancet. 2004 Feb 28;363(9410):734; author reply 734, 736. doi: 10.1016/S0140-6736(04)15675-4. Lancet. 2004. PMID: 15001334 No abstract available.

Comment on

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
Olsson SB; Executive Steering Committee of the SPORTIF III Investigators. Olsson SB, et al. Lancet. 2003 Nov 22;362(9397):1691-8. doi: 10.1016/s0140-6736(03)14841-6. Lancet. 2003. PMID: 14643116 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information